CLINICAL CHEMISTRY Flashcards
Functions of Enzymes
1)Hydration of Carbon Dioxide (respiration)
2)Nerve induction
3)Muscle contraction
4)Nutrient degradation (digestion)
5)Growth and Reproduction
6)Energy storage and use
Aspartate Aminotransferase (AST)
A.K.A
Serum Glutamic Oxaloacetic Transaminase (SGOT)
enzyme not specific to the liver, widely distributed, highest activities in cardiac, liver, and skeletal muscles
AST
most abundant isoenzyme of AST
Cytoplasmic
Increased AST isoenzyme that indicates cell necrosis
Mitochondrial
AST reaction:
Aspartate + a-ketoglutarate ⇌
Oxaloacetate + Glutamate
After MI, AST begins to rise in
6-8 hours
AST level peaks at ____ after MI
24 hours
AST returns to normal state ___ after MI
5 days
AST is increased in
Hepatocellular and Skeletal muscle disease
Chronic disease of the liver with progressive damage
Cofactor tightly bound to an enzyme
Prosthetic group
Oxidized form of NAD measures:
decreased absorbance
Reduced form of NADH measures
Increase absorbance
Assay for AST that uses malate dehydrogenase and monitors absorbance at 340 nm
Karmen method
Reference range for AST
5-30 u/L
Hemolyzed samples in AST results
Falsely increase
Karmen Method:
Oxaloacetate + NADH+H ⇌ (MD) ⇌
end product
malate + NAD+ (oxidized form)
Serum glutamic-pyruvic transaminase (SGPT)
AKA
Alanine Aminotransferase (ALT)
Liver specific enzymes
ALT
Increased in acute inflammatory conditions of the liver
Used to monitor the course of hepatitis treatment and the effects of drug therapy
Screening post transfusion hepatitis
Screen blood donors
Markedly increased in jaundice
Used as test for occupational toxic exposure
ALT
ALT reaction:
Alanine + a-ketoglutarate ⇌
pyruvate + glutamate
shows the result of the AST and ALT measurements
De Ritis Ratio
De Ritis Ratio:
Ratio > 1
AST> ALT
Non-viral origin
De Ritis Ratio:
Ratio < 1
AST < ALT
Viral origin
Assay for ALT uses
Lactate dehydrogenase
Assay for ALT end product
Alanine + a-ketoglutarate ⇌ pyruvate + glutamate
Pyruvate + NADH + H ⇌
Lactate + NAD+
Methods to Detect AST and ALT
Reitman and Frankel
Major organ affected in AST/SGOT
Heart
Major organ affected in SGPT/ALT
Liver
Substrate for SGOT/AST
Aspartic alphaketoglutaric acid
Substrate for SGPT/ALT
Alanine Alphaketoglutaric acid
End products for SGOT/AST
Glutamic acid + Oxaloacetic acid
End products for SGPT/ALT
Pyruvic acid + glutamic acid
Color developer for SGPT and SGOT
2,4 DNPH
Color intensifier for ALT/AST
0.4 N NaOh
Used for the diagnosis of hepatobiliary disorders and chronic alcoholism, obstructive jaundice
GGT
GGT is located in the canaliculi of the hepatic cells specifically in
epithelial lining of the biliary ductules
Sensitive marker for ethanol intoxication, occult alcoholism
GGT
Glutathione + amino acid ⇌
End product
glutamyl-peptide + L-cysteinylglycine
Szaz assay for GGT:
absorbs ____ and is measured at 405-430 nm
p-nitroaniline
End product of Szas Assay:
y-glutamyl-p-nitroanilide + glycerine → GGTP →
y-glutamyl-glycylglycine + p-nitroaniline
Alkaline Phosphatase
AKA
Alkaline orthophosphoric monoester phosphohydrolase
Liberates inorganic phosphate from an organic phosphate ester with production of alcohol
Alkaline phosphatase
Reference range of ALP in adult
30-90 u/L (adult)
Reference range of ALP in 0-3 months
70-220 u/L
Reference range of ALP in 3-10 years
50-260 u/L
Reference range of ALP in 10 years to puberty age
60-295 u/L
Source of ALP
Liver, Bone (osteoblast), placenta, intestine, and renal tissues
In vivo activity of ALP requires — activator (example of cofactor that enhances enzyme activity by altering the spatial configuration of the active site of the enzyme for substrate finding)
Mg2+
Useful for hepatobiliary disease and bone marrow disorders
ALP
ALP is significantly increased in
Paget’s disease or Osteitis deformans
Predominant isoenzyme of ALP
Bone and Liver
Assay for ALP based on molar absorptivity of p-nitrophenol
pH of 10.2
Bowers and McComb
End product of Bowers and McComb ALP
p-Nitrophenyl-phosphate ⇌ ALP ⇌
p-nitrophenol + phosphate ion
Color result for Bowers and McComb
yellow (405 nm)
Substrate for Bodansky, Shinowara, Jones, Reinheart - ALP
B-glycerophosphate
Substrate for Bessy, Lowry and Brock
p-nitrophenyl phosphate
Bowers and McComb substrate
p-nitrophenyl phosphate
King and Armstrong substrate
Phenyl phosphate
End product for bodansky, shinowara, jones, reinhart
ACP
Inorganic PO4 + glycerol
End product for bessy, lowry, and brock
p-nitrophenol (yellow)
King and Armstrong end product
phenol
Electrophoresis for ALP
Most anodal to Least Anodal
Liver > Bone > Placental > Intestinal
Fastest isoenzyme of ALP in electrophoresis
Liver
Heat labile fraction of ALP
Bone
Bone ALP is increased in
bone disease
healing of bone fractures
physiologic bone growth
Most heat stable fraction in ALP
Placental
Physiologic increase of ALP
Increased in 16th or 28th week of pregnancy
Pathologic increase in placental ALP
Malignancy or cancer (carcinoplacental)
Placental ALP withstand heating at
65 degC for 30 mins
Slowest moving fraction in blood group B or O
Intestinal ALP
Increased in fatty meal consumption and GIT disorder (Isoenzyme)
Intestinal ALP
Placental and Intestinal ALP are inhibited by
phenylalanine
Inhibits Bone ALP
3M Urea
Inhibits bone and liver isoenzyme
Levamisole
Total ALP elevations by liver or Bone ALP is differentiated by heating of serum at
56 deg C for 10 minutes
Most stable to Most Labile in heat stability of ALP
Placental > Intestinal > Liver> Bone
ALP residual activity is ↓ to >20%
Liver ALP
ALP residual activity is ↓ to <20%
BONE ALP
Lung, Breast, and Gynecological cancers, bone ALP co-migrator, most heat stable ALP
Specific ALP that is most heat stable
REGAN ALP
Adenocarcinoma of the Pancreas and Bile duct, Pleural cancer
Nagao ALP
Inhibited by Phenylalanine reagent only
REGAN
Inhibited by both Phenylalanine and L-leucine. (Alp isoenzyme)
Nagao
Acid Phosphatase AKA
Acid Orthophosphoric Monoester phosphohydrolase
Phosphomonoester + H2O ⇌ ACP ⇌
End product
Alcohol + Phosphate ion
Catalyze the hydrolysis of various phosphomonoester at an acid pH
ACP
Liberate inorganic phosphate from an organic phosphate ester with production of alcohol
ACP
ACP is present in
Prostate, RBCs, Platelets, Bone (osteoclasts)
The activity of ACP in the seminal fluid is only demostrated for up to
4 days
inhibits specific prostatic ACP
L-tartrate ions
inhibits red cell ACP
Formaldehyde and Cupric ions
Reference Range: Prostatic ACP
0-3.5 ng/mL
Assay for ACP quantitative substrate
thymolpthalein monophosphate
Assay for ACP continuous substrate
a-napthyl phosphate
Assay for ACP gutman and gutman substrate
phenyl po4
Assay for ACP shinowara substrate
pnpp